These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17327408)

  • 1. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.
    Cerhan JR; Wang S; Maurer MJ; Ansell SM; Geyer SM; Cozen W; Morton LM; Davis S; Severson RK; Rothman N; Lynch CF; Wacholder S; Chanock SJ; Habermann TM; Hartge P
    Blood; 2007 Jun; 109(12):5439-46. PubMed ID: 17327408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.
    Habermann TM; Wang SS; Maurer MJ; Morton LM; Lynch CF; Ansell SM; Hartge P; Severson RK; Rothman N; Davis S; Geyer SM; Cozen W; Chanock SJ; Cerhan JR
    Blood; 2008 Oct; 112(7):2694-702. PubMed ID: 18633131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide variants in immune-response genes and the tumor microenvironment composition predict progression of mantle cell lymphoma.
    Assis-Mendonça GR; Fattori A; Rocha RM; Lourenço GJ; Delamain MT; Nonogaki S; de Lima VCC; Colleoni GWB; de Souza CA; Soares FA; Lima CSP; Vassallo J
    BMC Cancer; 2021 Mar; 21(1):209. PubMed ID: 33648463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival.
    Baecklund F; Foo JN; Bracci P; Darabi H; Karlsson R; Hjalgrim H; Rosenquist R; Adami HO; Glimelius B; Melbye M; Conde L; Liu J; Humphreys K; Skibola CF; Smedby KE
    BMC Med Genet; 2014 Oct; 15():113. PubMed ID: 25294155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma.
    Charbonneau B; Maurer MJ; Fredericksen ZS; Zent CS; Link BK; Novak AJ; Ansell SM; Weiner GJ; Wang AH; Witzig TE; Dogan A; Slager SL; Habermann TM; Cerhan JR
    Am J Hematol; 2012 Sep; 87(9):880-5. PubMed ID: 22718493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.
    Huet S; Tesson B; Jais JP; Feldman AL; Magnano L; Thomas E; Traverse-Glehen A; Albaud B; Carrère M; Xerri L; Ansell SM; Baseggio L; Reyes C; Tarte K; Boyault S; Haioun C; Link BK; Feugier P; Lopez-Guillermo A; Tilly H; Brice P; Hayette S; Jardin F; Offner F; Sujobert P; Gentien D; Viari A; Campo E; Cerhan JR; Salles G
    Lancet Oncol; 2018 Apr; 19(4):549-561. PubMed ID: 29475724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in immune function genes and non-Hodgkin lymphoma survival.
    Aschebrook-Kilfoy B; Zheng T; Foss F; Ma S; Han X; Lan Q; Holford T; Chen Y; Leaderer B; Rothman N; Zhang Y
    J Cancer Surviv; 2012 Mar; 6(1):102-14. PubMed ID: 22113576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
    Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O
    Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study.
    Rossi D; Bruscaggin A; La Cava P; Galimberti S; Ciabatti E; Luminari S; Rigacci L; Tucci A; Pulsoni A; Bertoldero G; Vallisa D; Rusconi C; Spina M; Arcaini L; Angrilli F; Stelitano C; Merli F; Gaidano G; Federico M; Palumbo GA
    Haematologica; 2015 Apr; 100(4):517-24. PubMed ID: 25596266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical features, survival analysis, and geriatric assessment of 85 patients with follicular lymphoma: a single-center study].
    Yin JJ; Qian L; Bai JF; Feng R; Li JT; Wang T; Zhang CL; Liu H
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):233-241. PubMed ID: 38716594
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.
    Dave SS; Wright G; Tan B; Rosenwald A; Gascoyne RD; Chan WC; Fisher RI; Braziel RM; Rimsza LM; Grogan TM; Miller TP; LeBlanc M; Greiner TC; Weisenburger DD; Lynch JC; Vose J; Armitage JO; Smeland EB; Kvaloy S; Holte H; Delabie J; Connors JM; Lansdorp PM; Ouyang Q; Lister TA; Davies AJ; Norton AJ; Muller-Hermelink HK; Ott G; Campo E; Montserrat E; Wilson WH; Jaffe ES; Simon R; Yang L; Powell J; Zhao H; Goldschmidt N; Chiorazzi M; Staudt LM
    N Engl J Med; 2004 Nov; 351(21):2159-69. PubMed ID: 15548776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
    Richendollar BG; Pohlman B; Elson P; Hsi ED
    Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.
    Wang SS; Maurer MJ; Morton LM; Habermann TM; Davis S; Cozen W; Lynch CF; Severson RK; Rothman N; Chanock SJ; Hartge P; Cerhan JR
    Leukemia; 2009 Mar; 23(3):596-602. PubMed ID: 18830263
    [No Abstract]   [Full Text] [Related]  

  • 14. Inherited genetic variation and overall survival following follicular lymphoma.
    Gibson TM; Wang SS; Cerhan JR; Maurer MJ; Hartge P; Habermann TM; Davis S; Cozen W; Lynch CF; Severson RK; Rothman N; Chanock SJ; Morton LM
    Am J Hematol; 2012 Jul; 87(7):724-6. PubMed ID: 22473939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in the metabolic pathway and non-Hodgkin lymphoma survival.
    Han X; Zheng T; Foss FM; Lan Q; Holford TR; Rothman N; Ma S; Zhang Y
    Am J Hematol; 2010 Jan; 85(1):51-6. PubMed ID: 20029944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the Follicular Lymphoma International Prognostic Index and the International Prognostic Index in assessing prognosis and predicting first-line treatment efficacy in follicular lymphoma patients.
    Formica V; Norman AR; Cunningham D; Wotherspoon A; Oates J; Chong G
    Acta Haematol; 2009; 122(4):193-9. PubMed ID: 19887775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy.
    Maeng CH; Ahn SW; Ryu SY; Han S; Ko YH; Ji JH; Kim WS; Kim SJ
    Korean J Intern Med; 2016 May; 31(3):560-9. PubMed ID: 26898595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The associations between immunity-related genes and breast cancer prognosis in Korean women.
    Choi J; Song N; Han S; Chung S; Sung H; Lee JY; Jung S; Park SK; Yoo KY; Han W; Lee JW; Noh DY; Kang D; Choi JY
    PLoS One; 2014; 9(7):e103593. PubMed ID: 25075970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of the CDKN2A tumor-suppressor gene by deletion or methylation is common at diagnosis in follicular lymphoma and associated with poor clinical outcome.
    Alhejaily A; Day AG; Feilotter HE; Baetz T; Lebrun DP
    Clin Cancer Res; 2014 Mar; 20(6):1676-86. PubMed ID: 24449825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy.
    Murakami S; Kato H; Higuchi Y; Yamamoto K; Yamamoto H; Saito T; Taji H; Yatabe Y; Nakamura S; Kinoshita T
    Ann Hematol; 2016 Aug; 95(8):1259-69. PubMed ID: 27220639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.